(MedPage Today) — Memantine hydrochloride, a noncompetitive NMDA receptor antagonist, may help improve social impairment in a specific subset of youth with autism spectrum disorder (ASD), a small trial suggested.
Nine of 16 youth (56.2%) treated…
Source link : https://www.medpagetoday.com/pediatrics/autism/117750
Author :
Publish date : 2025-10-01 21:36:00
Copyright for syndicated content belongs to the linked Source.
